Cutaneous T-cell Lymphoma Diagnostic and Therapeutic Trends amidst the COVID-19 Pandemic
DOI:
https://doi.org/10.2340/actadv.v104.40505Keywords:
ctcl, covid19, lymphoma, mogamulizumab, brentuximab, photherapyAbstract
Abstract is missing (Short communication)
Downloads
References
De Santis KK, Helmer S, Barnes B, Kraywinkel K, Imhoff M, Müller-Ebersteinet R, et al. Impact of the COVID-19 pandemic on oncological care in Germany: rapid review. J Cancer Res Clin Oncol 2023; 149: 14329-14340.
https://doi.org/10.1007/s00432-023-05063-9 DOI: https://doi.org/10.1007/s00432-023-05063-9
Caini S, Brusasco M, Niero G, De Giorgi V, Lombardo M, Massone C, et al. Healthcare and safety of patients with melanoma during the COVID-19 pandemic in Italy. J Eur Acad Dermatol Venereol 2022; 36: 1669.
https://doi.org/10.1111/jdv.18056 DOI: https://doi.org/10.1111/jdv.18056
Geskin LJ, Kwinta BD, Garcia-Saleem TJ, Akilov OE, Enz PA, Guenova E, et al. International Society for Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of cutaneous T-cell lymphoma outcomes during the COVID-19 pandemic: a retrospective cohort study. J Am Acad Dermatol 2023; 88: 935-937.
https://doi.org/10.1016/j.jaad.2022.11.016 DOI: https://doi.org/10.1016/j.jaad.2022.11.016
Elmasry MF, Youssef R, Elbendary A, Helmy K, Abdelkader HA. Cutaneous lymphomas and COVID-19: what is known so far? Dermatol Ther 2021; 34: e14463.
https://doi.org/10.1111/dth.14463 DOI: https://doi.org/10.1111/dth.14463
Willemze R, Cerroni L, Kempf W, Berti E, Facchetti F, Swerdlow SH, et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood 2019; 133: 1703-1714.
https://doi.org/10.1182/blood-2018-11-881268 DOI: https://doi.org/10.1182/blood-2018-11-881268
Roccuzzo G, Giordano S, Avallone G, Rubatto M, Canonico S, Funaro A, et al. Sézary syndrome: different erythroderma morphological features with proposal for a clinical score system. Cells 2022; 11: 333.
https://doi.org/10.3390/cells11030333 DOI: https://doi.org/10.3390/cells11030333
Olsen EA, Whittaker S, Willemze R, Pinter-Brown L, Francine Foss F, Geskin L, et al. Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC. Blood 2022; 140: 419-437.
https://doi.org/10.1182/blood.2021012057 DOI: https://doi.org/10.1182/blood.2021012057
Quaglino P, Scarisbrick J, Roccuzzo G, Albeldano A, Battistella M, McCormack C, et al. Identifying unmet needs and challenges in the definition of a plaque in mycosis fungoides: an EORTC-CLTG/ISCL survey. J Eur Acad Dermatol Venereol 2023; 37: 680-688.
https://doi.org/10.1111/jdv.18852 DOI: https://doi.org/10.1111/jdv.18852
Latzka J, Assaf C, Bagot M, Cozzio A, Dummer R, Guenova E, et al. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome: Update 2023. Eur J Cancer 2023; 195: 113343.
https://doi.org/10.1016/j.ejca.2023.113343 DOI: https://doi.org/10.1016/j.ejca.2023.113343
Macagno N, Mastorino L, Rubatto M, Avallon G, Merli M, Agostini A, et al. Primary cutaneous lymphoma patients seen at a referral dermatological centre in 1 year: a single-centre observational retrospective cohort study of the diagnoses and staging, comorbidities and associated symptoms, treatment performed and clinical course. J Eur Acad Dermatol Venereol 2022; 36: 2388-2392.
https://doi.org/10.1111/jdv.18469 DOI: https://doi.org/10.1111/jdv.18469
Avallone G, Quaglino P, Cavallo F, Roccuzzo G, Ribero S, Zalaudek I, et al. SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review. Int J Dermatol 2022; 61: 1187-1204.
https://doi.org/10.1111/ijd.16063 DOI: https://doi.org/10.1111/ijd.16063
Costa FB, Baptista PL, Duquia RP. A cross-sectional questionnaire study in a phototherapy unit during COVID-19. Photochem Photobiol Sci 2021; 20: 1239-1242.
https://doi.org/10.1007/s43630-021-00093-z DOI: https://doi.org/10.1007/s43630-021-00093-z
Papadavid E, Scarisbrick J, Ortiz Romero P, Quaglino P, Vermeer M, Knobler R, et al. Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines. J Eur Acad Dermatol Venereol 2020; 34: 1633-1636.
https://doi.org/10.1111/jdv.16593 DOI: https://doi.org/10.1111/jdv.16593
Jiang J, Böhringer D, Auw-Hädrich C, Maier PC, Barth T, Eter N, et al. Current practice in the treatment of epithelial and melanocytic tumours with interferon-α2b: a survey of tertiary eye centres in Germany. Klin Monbl Augenheilkd 2023; 240: 891-896.
https://doi.org/10.1055/a-2029-0163 DOI: https://doi.org/10.1055/a-2029-0163
Roccuzzo G, Giordano S, Fava P, Pileri A, Guglielmo A, Tonella L, et al. Immune check point inhibitors in primary cutaneous t-cell lymphomas: biologic rationale, clinical results and future perspectives. Front Oncol 2021; 11: 733770.
https://doi.org/10.3389/fonc.2021.733770 DOI: https://doi.org/10.3389/fonc.2021.733770
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Gabriele Roccuzzo, Nicole Macagno, Cristina Sarda, Jelena Pisano, Simone Ribero, Paolo Fava, Pietro Quaglino
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
